Lv4
490 积分 2024-01-22 加入
Sacituzumab Govitecan In Platinum-Resistant Epithelial Ovarian Cancer In A Real-Life Clinical Setting
13天前
已关闭
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
14天前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
14天前
已完结
Successful SequentialUse of the Antibody-drug-Conjugate Trastuzumab Deruxtecan after Progression on Sacituzumab Govitecan in a Heavily Pretreated Platinum-Resistant, High Grade Serous Ovarian Cancer Patient
15天前
已完结
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
8个月前
已完结
中国绝经管理与绝经激素治疗指南2023版
8个月前
已完结
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
8个月前
已完结
A double-blind, randomized trial of local formic acid puncture technique in the treatment of common warts
9个月前
已关闭
Pathophysiology and Management of Hyperoxaluria and Oxalate Nephropathy: A Review
9个月前
已完结
皖公网安备34019202002308
